BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 28968506)

  • 1. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study.
    Milroy LG; Brunsveld L; Ottmann C
    ACS Chem Biol; 2013 Jan; 8(1):27-35. PubMed ID: 23210482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3: A Case Study in PPI Modulation.
    Ballone A; Centorrino F; Ottmann C
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecules modulation of 14-3-3 protein-protein interactions.
    Mori M; Vignaroli G; Botta M
    Drug Discov Today Technol; 2013 Dec; 10(4):e541-7. PubMed ID: 24451646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of modulators of protein-protein interactions: current approaches and limitations.
    Meireles LM; Mustata G
    Curr Top Med Chem; 2011; 11(3):248-57. PubMed ID: 21320056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Modulators of Protein-Protein Interactions (PPIs).
    Ni D; Liu N; Sheng C
    Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical candidates modulating protein-protein interactions: The fragment-based experience.
    Valenti D; Hristeva S; Tzalis D; Ottmann C
    Eur J Med Chem; 2019 Apr; 167():76-95. PubMed ID: 30769242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insight into specific 14-3-3 modulators: Inhibitors and stabilisers of protein-protein interactions of 14-3-3.
    Hartman AM; Hirsch AKH
    Eur J Med Chem; 2017 Aug; 136():573-584. PubMed ID: 28549334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Compound Classes: Protein-Protein Interactions.
    Ottmann C
    Handb Exp Pharmacol; 2016; 232():125-38. PubMed ID: 26489828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of Protein-Protein Interactions in chemical biology and drug discovery.
    Bier D; Thiel P; Briels J; Ottmann C
    Prog Biophys Mol Biol; 2015 Oct; 119(1):10-9. PubMed ID: 26093250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, Function, Involvement in Diseases and Targeting of 14-3-3 Proteins: An Update.
    Cau Y; Valensin D; Mori M; Draghi S; Botta M
    Curr Med Chem; 2018; 25(1):5-21. PubMed ID: 28462702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics.
    Petta I; Lievens S; Libert C; Tavernier J; De Bosscher K
    Mol Ther; 2016 Apr; 24(4):707-18. PubMed ID: 26675501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
    Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
    J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide therapeutics: targeting the undruggable space.
    Tsomaia N
    Eur J Med Chem; 2015 Apr; 94():459-70. PubMed ID: 25591543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-protein interactions: network analysis and applications in drug discovery.
    Bultinck J; Lievens S; Tavernier J
    Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers.
    Sijbesma E; Hallenbeck KK; Leysen S; de Vink PJ; Skóra L; Jahnke W; Brunsveld L; Arkin MR; Ottmann C
    J Am Chem Soc; 2019 Feb; 141(8):3524-3531. PubMed ID: 30707565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.